Document Detail


Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.
MedLine Citation:
PMID:  20433909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recently identified candidate susceptibility genes for schizophrenia are likely to play, important roles in the pathophysiology of the illness. It is also clear, however, that the etiologic, contribution of these genes is not only via their own functions but also through interactions with other, genes and environmental factors. Genetic, transgenic and postmortem brain studies support a, potential role for NRG1-erbB4 signaling in schizophrenia. Embedded in the results of these studies, however, are clues to the notion that NRG1-erbB4 signaling does not act alone but in conjunction with, other pathways. This article aims to re-evaluate the evidence for the role of neuregulin 1 (NRG1)-erbB4 signaling in schizophrenia by focusing on its interactions with other candidate susceptibility, pathways. In addition, we consider molecular substrates upon which the NRG1-erbB4 and other, candidate pathways converge contributing to susceptibility for the illness (schizophrenia interactome). Glutamatergic signaling can be an interesting candidate for schizophrenia interactome. Schizophrenia is associated with NMDA receptor hypofunction and moreover, several susceptibility genes for, schizophrenia converge on NMDA receptor signaling. These candidate genes influence NMDA receptor, signaling via diverse mechanisms, yet all eventually impact on protein composition of NMDA receptor, complexes. Likewise, the protein associations in the receptor complexes can themselves modulate, signaling molecules of candidate genes and their pathways. Therefore, protein-protein interactions in the NMDA receptor complexes can mediate reciprocal interactions between NMDA receptor function, and susceptibility candidate pathways including NRG1-erbB4 signaling and thus can be a, schizophrenia interactome.
Authors:
Anamika Banerjee; Mathew L Macdonald; Karin E Borgmann-Winter; Chang-Gyu Hahn
Related Documents :
9042569 - The concerted activity in parallel proprioceptive pathways controls the initiation of c...
21630509 - Nonpeptidic delta (delta) opioid agonists and antagonists of the diarylmethylpiperazine...
14625689 - Receptor and nonreceptor protein tyrosine phosphatases in the nervous system.
9436979 - Smad6 inhibits bmp/smad1 signaling by specifically competing with the smad4 tumor suppr...
21104389 - Integration of endocannabinoid signaling into the neural network regulating stress-indu...
17413039 - Modulation of tissue factor-factor viia signaling by lipid rafts and caveolae.
9661029 - Determination of the excitatory potencies of fluoroquinolones in the central nervous sy...
12202489 - C-myc augments the apoptotic activity of cytosolic death receptor signaling proteins by...
7508579 - Distribution and co-localization of 5-hydroxytryptamine, thyrotropin-releasing hormone ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2010-04-28
Journal Detail:
Title:  Brain research bulletin     Volume:  83     ISSN:  1873-2747     ISO Abbreviation:  Brain Res. Bull.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-17     Completed Date:  2011-01-06     Revised Date:  2011-11-02    
Medline Journal Info:
Nlm Unique ID:  7605818     Medline TA:  Brain Res Bull     Country:  United States    
Other Details:
Languages:  eng     Pagination:  132-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104-3403, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Humans
Neuregulin-1 / genetics*
Receptor, Epidermal Growth Factor / genetics*
Receptors, N-Methyl-D-Aspartate / physiology
Schizophrenia / genetics*,  pathology*
Signal Transduction / physiology*
Grant Support
ID/Acronym/Agency:
R01 MH075916-04/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Neuregulin-1; 0/Receptors, N-Methyl-D-Aspartate; EC 2.7.10.1/Receptor, Epidermal Growth Factor; EC 2.7.10.1/receptor tyrosine-protein kinase erbB-4

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mouse behavioral endophenotypes for schizophrenia.
Next Document:  Genome-wide approaches to schizophrenia.